Albumin Human Patent Expiration

Albumin Human is Used for enhancing ultrasound imaging during medical procedures. It was first introduced by Ge Healthcare in its drug Optison on Dec 31, 1997.


Albumin Human Patents

Given below is the list of patents protecting Albumin Human, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Optison US6723303 Ultrasound contrast agents including protein stabilized microspheres of perfluoropropane, perfluorobutane or perfluoropentane Apr 20, 2021

(Expired)

Ge Healthcare
Optison US5529766 Contrast agents Jun 25, 2013

(Expired)

Ge Healthcare



Albumin Human's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List